Inventor profile of:

John Frederick Boylan

City:

Bedminster, New Jersey

Country:

United States

Published Applications:

20

Last publication date:

2023-05-25

Top Assignees for applications by John Frederick Boylan

The entities that hold a legal rights for patent applications filed by inventor Boylan John Frederick:

Recent patent applications by Boylan John Frederick

John Frederick Boylan from Bedminster, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-05-25
US20230158035A1
Human necessities

SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

#2 | 2021-05-06
US20210128565A1
Human necessities

Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith

#3 | 2020-09-03
US20200277610A1
Chemistry; metallurgy

Compositions and methods for inhibiting expression of RRM2 genes

#4 | 2020-07-30
US20200237768A1
Human necessities

Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith

#5 | 2019-11-07
US20190336507A1
Human necessities

Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith

#6 | 2018-07-12
US20180195074A1
Chemistry; metallurgy

Compositions and methods for inhibiting expression of RRM2 genes

#7 | 2017-05-18
US20170137827A1
Chemistry; metallurgy

Compositions and methods for inhibiting expression of RRM2 genes

#8 | 2017-02-16
US20170042902A1
Human necessities

Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith

#9 | 2016-04-07
US20160096841A1
Chemistry; metallurgy

Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith

#10 | 2015-04-23
US20150113670A1
Chemistry; metallurgy

Compositions and Methods for Inhibiting Expression of RRM2 Genes

#11 | 2014-12-04
US20140357620A1
Human necessities

METHOD FOR ADMINISTRATION OF A GAMMA SECRETASE INHIBITOR

#12 | 2013-10-24
US20130281437A1
Human necessities

Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor

#13 | 2013-03-28
US20130079383A1
Chemistry; metallurgy

Lipid Compounds Targeting VLA-4

#14 | 2013-03-21
US20130072543A1
Human necessities

Compounds and Compositions for Nucleic Acid Formulation and Delivery

#15 | 2012-09-06
US20120225860A1
Human necessities

METHOD FOR ADMINISTRATION OF A GAMMA SECRETASE INHIBITOR

#16 | 2012-06-21
US20120159657A1
Chemistry; metallurgy

Compositions and methods for inhibiting expression of RRM2 genes

#17 | 2011-11-24
US20110287025A1
Physics

Combination therapy and method for assessing resistance to treatment

#18 | 2011-05-12
US20110112176A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF KIF10 GENES

#19 | 2009-07-16
US20090181944A1
Human necessities

METHOD FOR CANCER THERAPY

#20 | 2007-08-30
US20070203210A1
Chemistry; metallurgy

Thiazolyl-benzimidazoles

InventorID:

154521 ⎘